BSE has signed an agreement with MSCI to explore launching futures and options contracts linked to global MSCI indexes in India. While this move aims to attract more institutional capital and broaden product offerings, the launch remains subject to regulatory approval. Investors are also monitoring how the exchange manages recent declines in options turnover and broader market regulatory pressures.
BSE Ltd. has officially partnered with global index provider MSCI to bring new futures and options products to the Indian market. The agreement focuses on developing derivatives linked to MSCI indexes, which serve as key benchmarks for institutional investors worldwide. This collaboration is designed to provide fund managers and traders with new tools to hedge their exposure to the Indian equity market.
Expanding Product Reach
The strategic value of this partnership lies in the global influence of MSCI benchmarks. As of December 31, 2025, over $21 trillion in assets under management were tracked against MSCI indexes globally. By offering derivatives linked to these indexes, BSE aims to enhance market accessibility and potentially drive higher trading volumes. BSE CEO Sundararaman Ramamurthy emphasized that the initiative is intended to provide investors with additional avenues to manage risk and access the Indian market more effectively.
The Regulatory Hurdle
Investors should be aware that this project is not an immediate launch. The initiative is currently contingent upon receiving necessary approvals from market regulators. In the current market environment, the exchange sector has been sensitive to regulatory shifts, such as changes to the Securities Transaction Tax (STT), which can influence trading volumes. Because a significant portion of an exchange's revenue comes from transaction-related fees, regulatory stability remains a primary factor for the business.
Valuation and Performance Context
The announcement comes at a time when the market is carefully assessing BSE’s growth trajectory against its valuation. The stock, which closed at approximately ₹3,352 on August 19, 2026, is trading at a forward valuation of around 44 times expected earnings. While the company reported strong financial results for the quarter ending March 2026, with revenue of ₹1,468 crore and an EPS of ₹19.62, analysts have flagged potential risks.
Some brokerage reports have pointed to downward pressure on earnings estimates—by 5-12%—citing headwinds from regulatory changes and competitive pressures. Furthermore, BSE has seen a softening in its options turnover, with volumes declining by roughly 12% in August 2026 compared to the previous month. The company's ability to maintain its market share in the derivatives segment remains a critical monitorable for shareholders.
The next important update for investors will be the timeline for regulatory approval and any management commentary regarding the expected launch date of these new products. Market participants will also continue to watch monthly trading volume data to see if the recent cooling in options activity stabilizes.